Pfizer Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	62,579	63,627	59,553	101,175	81,288
Revenue Growth (YoY)	-1.65%	6.84%	-41.14%	24.46%	95.17%
Cost of Revenue	16,067	17,851	24,954	34,344	30,821
Gross Profit	46,512	45,776	34,599	66,831	50,467
Selling, General & Admin	13,794	14,730	14,771	13,677	12,703
Depreciation & Amortization Expenses	4,874	5,286	4,733	3,609	3,700
Research & Development	12,050	10,930	10,873	12,381	13,829
Other Operating Expenses	8,274	6,807	3,165	2,437	-4,076
Total Operating Expenses	38,992	37,753	33,542	32,104	26,156
Operating Income	7,520	8,023	1,057	34,727	24,311
Pretax Income	7,520	8,023	1,058	34,729	24,311
Provision for Income Taxes	-266	-28	-1,115	3,328	1,852
Net Income	7,771	8,031	2,119	31,372	21,979
Minority Interest in Earnings	41	31	39	35	45
Earnings From Discontinued Operations	25	11	-15	6	-434
Net Income to Common	7,771	8,031	2,119	31,372	21,979
Net Income Growth	-3.24%	279.00%	-93.25%	42.74%	139.97%
Shares Outstanding (Basic)	5,683	5,664	5,643	5,608	5,601
Shares Outstanding (Diluted)	5,713	5,700	5,709	5,733	5,708
Shares Change (YoY)	0.23%	-0.16%	-0.42%	0.44%	1.35%
EPS (Basic)	1.37	1.42	0.38	5.59	3.92
EPS (Diluted)	1.36	1.41	0.37	5.47	3.85
EPS Growth	-3.55%	281.08%	-93.24%	42.08%	226.27%
Shares Outstanding	5,686	5,667	5,646	5,616	5,620
Free Cash Flow	9,075	9,835	4,793	26,031	29,869
Free Cash Flow Growth	-7.73%	105.19%	-81.59%	-12.85%	145.29%
Free Cash Flow Per Share	1.59	1.73	0.84	4.54	5.23
Dividends Per Share	1.720	1.680	1.640	1.600	1.560
Dividend Growth	2.38%	2.44%	2.50%	2.56%	2.63%
Gross Margin	74.33%	71.94%	58.10%	66.05%	62.08%
Operating Margin	12.02%	12.61%	1.77%	34.32%	29.91%
Profit Margin	12.44%	12.65%	3.65%	31.04%	27.63%
FCF Margin	14.50%	15.46%	8.05%	25.73%	36.74%
EBITDA	14,112	15,036	7,347	39,791	29,502
EBITDA Margin	22.55%	23.63%	12.34%	39.33%	36.29%
EBIT	7,520	8,023	1,057	34,727	24,311
EBIT Margin	12.02%	12.61%	1.77%	34.32%	29.91%
Effective Tax Rate	-3.54%	-0.35%	-105.39%	9.58%	7.62%

Updated Feb 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q